NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: insight from the On-TIME II trial
Background - N-terminal fragment of the brain natriuretic peptide prohormone (NT-proBNP), a marker for neurohumoral activation, has been associated with adverse outcome in patients with myocardial infarction. NT-proBNP levels may reflect extensive ischemia and microvascular damage, therefore we inve...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
American heart journal
Year: 2021, Jahrgang: 233, Pages: 78-85 |
| ISSN: | 1097-6744 |
| DOI: | 10.1016/j.ahj.2020.12.017 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ahj.2020.12.017 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0002870320304269 
|
| Verfasserangaben: | Enrico Fabris, MD, PhD, Jurrien M. ten Berg, MD, PhD, Renicus S. Hermanides, MD, PhD, Jan Paul Ottervanger, MD, PhD, Jan Henk E Dambrink, MD, PhD, AT Marcel Gosselink, MD, PhD, Gianfranco Sinagra, MD, Petra C.Koopmans, PhD, Evangelos Giannitsis, MD, PhD, ChristianHamm, MD, PhD, and Arnoud W.J. van’t Hof, MD, PhD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1753532248 | ||
| 003 | DE-627 | ||
| 005 | 20220819160738.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210409s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ahj.2020.12.017 |2 doi | |
| 035 | |a (DE-627)1753532248 | ||
| 035 | |a (DE-599)KXP1753532248 | ||
| 035 | |a (OCoLC)1341403956 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fabris, Enrico |e VerfasserIn |0 (DE-588)1171143729 |0 (DE-627)1040384072 |0 (DE-576)513604669 |4 aut | |
| 245 | 1 | 0 | |a NT-proBNP level before primary PCI and risk of poor myocardial reperfusion |b insight from the On-TIME II trial |c Enrico Fabris, MD, PhD, Jurrien M. ten Berg, MD, PhD, Renicus S. Hermanides, MD, PhD, Jan Paul Ottervanger, MD, PhD, Jan Henk E Dambrink, MD, PhD, AT Marcel Gosselink, MD, PhD, Gianfranco Sinagra, MD, Petra C.Koopmans, PhD, Evangelos Giannitsis, MD, PhD, ChristianHamm, MD, PhD, and Arnoud W.J. van’t Hof, MD, PhD |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 31 December 2020 | ||
| 500 | |a Gesehen am 07.09.2021 | ||
| 520 | |a Background - N-terminal fragment of the brain natriuretic peptide prohormone (NT-proBNP), a marker for neurohumoral activation, has been associated with adverse outcome in patients with myocardial infarction. NT-proBNP levels may reflect extensive ischemia and microvascular damage, therefore we investigated the potential association between baseline NT-proBNP level and ST-resolution (STR), a marker of myocardial reperfusion, after primary percutaneous coronary intervention (pPCI). - Methods - we performed a post-hoc analysis of the On-TIME II trial (which randomized ST-elevation myocardial infarction (STEMI) patients to pre-hospital tirofiban administration vs placebo). Patients with measured NT-proBNP before angiography were included. Multivariate logistic-regression analyses was performed to investigate the association between baseline NTproBNP level and STR one hour after pPCI. - Results - Out of 984 STEMI patients, 918 (93.3%) had NT-proBNP values at baseline. Patients with STR <70% had higher NT-proBNP values compared to patients with complete STR (>70%) [Mean ±SD 375.2 ±1021.7 vs 1007.4 ±2842.3, Median (IQR) 111.7 (58.4-280.0) vs 168.0 (62.3-601.3), P <.001]. At multivariate logistic regression analysis, independent predictors associated with higher risk of poor myocardial reperfusion (STR <70%) were: NT-proBNP (OR 1.17, 95%CI 1.04-1.31, P=.009), diabetes mellitus (OR 1.87, 95%CI 1.14-3.07, P=.013), anterior infarct location (OR 2.74, 95% CI 2.00-3.77, P <.001), time to intervention (OR 1.06, 95%CI 1.01-1.11, P=.021), randomisation to placebo (OR 1.45, 95%CI 1.05-1.99, P=.022). - Conclusions - In STEMI patients, higher baseline NT-proBNP level was independently associate with higher risk of poor myocardial reperfusion, supporting the potential use of NT-proBNP as an early marker for risk stratification of myocardial reperfusion after pPCI in STEMI patients. | ||
| 700 | 1 | |a ten Berg, Jurrien M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hermanides, Renicus S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ottervanger, Jan Paul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dambrink, Jan Henk E |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gosselink, AT Marcel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sinagra, Gianfranco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koopmans, Petra C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Giannitsis, Evangelos |e VerfasserIn |0 (DE-588)113336241 |0 (DE-627)577184091 |0 (DE-576)289759579 |4 aut | |
| 700 | 1 | |a Hamm, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a van ’t Hof, Arnoud W. J. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American heart journal |d Amsterdam [u.a.] : Elsevier, 1925 |g 233(2021), Seite 78-85 |h Online-Ressource |w (DE-627)313061718 |w (DE-600)2003210-9 |w (DE-576)090883500 |x 1097-6744 |7 nnas |a NT-proBNP level before primary PCI and risk of poor myocardial reperfusion insight from the On-TIME II trial |
| 773 | 1 | 8 | |g volume:233 |g year:2021 |g pages:78-85 |g extent:8 |a NT-proBNP level before primary PCI and risk of poor myocardial reperfusion insight from the On-TIME II trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ahj.2020.12.017 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0002870320304269 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210409 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 113336241 |a Giannitsis, Evangelos |m 113336241:Giannitsis, Evangelos |d 910000 |d 910100 |d 50000 |e 910000PG113336241 |e 910100PG113336241 |e 50000PG113336241 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 9 | ||
| 999 | |a KXP-PPN1753532248 |e 3904223577 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Available online 31 December 2020","Gesehen am 07.09.2021"],"person":[{"family":"Fabris","role":"aut","given":"Enrico","display":"Fabris, Enrico"},{"role":"aut","family":"ten Berg","display":"ten Berg, Jurrien M.","given":"Jurrien M."},{"family":"Hermanides","role":"aut","display":"Hermanides, Renicus S.","given":"Renicus S."},{"given":"Jan Paul","display":"Ottervanger, Jan Paul","role":"aut","family":"Ottervanger"},{"role":"aut","family":"Dambrink","given":"Jan Henk E","display":"Dambrink, Jan Henk E"},{"given":"AT Marcel","display":"Gosselink, AT Marcel","role":"aut","family":"Gosselink"},{"role":"aut","family":"Sinagra","given":"Gianfranco","display":"Sinagra, Gianfranco"},{"role":"aut","family":"Koopmans","display":"Koopmans, Petra C.","given":"Petra C."},{"role":"aut","family":"Giannitsis","display":"Giannitsis, Evangelos","given":"Evangelos"},{"given":"Christian","display":"Hamm, Christian","family":"Hamm","role":"aut"},{"display":"van ’t Hof, Arnoud W. J.","given":"Arnoud W. J.","family":"van ’t Hof","role":"aut"}],"recId":"1753532248","language":["eng"],"name":{"displayForm":["Enrico Fabris, MD, PhD, Jurrien M. ten Berg, MD, PhD, Renicus S. Hermanides, MD, PhD, Jan Paul Ottervanger, MD, PhD, Jan Henk E Dambrink, MD, PhD, AT Marcel Gosselink, MD, PhD, Gianfranco Sinagra, MD, Petra C.Koopmans, PhD, Evangelos Giannitsis, MD, PhD, ChristianHamm, MD, PhD, and Arnoud W.J. van’t Hof, MD, PhD"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"relHost":[{"part":{"extent":"8","pages":"78-85","text":"233(2021), Seite 78-85","volume":"233","year":"2021"},"language":["eng"],"note":["Gesehen am 21.09.2020"],"pubHistory":["1.1925 -"],"disp":"NT-proBNP level before primary PCI and risk of poor myocardial reperfusion insight from the On-TIME II trialAmerican heart journal","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"AHJ"}],"recId":"313061718","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["313061718"],"issn":["1097-6744"],"zdb":["2003210-9"]},"title":[{"title_sort":"American heart journal","subtitle":"AHJ","title":"American heart journal"}],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo.","dateIssuedKey":"1925","dateIssuedDisp":"1925-","publisher":"Elsevier ; Mosby"}]}],"physDesc":[{"extent":"8 S."}],"id":{"eki":["1753532248"],"doi":["10.1016/j.ahj.2020.12.017"]},"title":[{"title_sort":"NT-proBNP level before primary PCI and risk of poor myocardial reperfusion","subtitle":"insight from the On-TIME II trial","title":"NT-proBNP level before primary PCI and risk of poor myocardial reperfusion"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a FABRISENRINTPROBNPLE2021 | ||